Elcon Drugs And Formulations Limited, a active public limited company, was established on 04 January 1994 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232RJ1994PLC007922. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹7.72 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Amit Khandelwal (Whole-Time Director), Shiven Khandelwal (Whole-Time Director), Anuradha Khandelwal (Whole-Time Director). Past directors included Kailash Khandelwal, Amit Khandelwal, Naveen Khandelwal. It holds ₹4.47 M open charges and ₹5.85 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G-2, G-3, G R Tower, Hathoj Mod, Bindayaka Road, Jaipur, Rajasthan, 302012.
U24232RJ1994PLC007922
007922
04 January 1994
₹8.00 M
₹7.72 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Elcon Drugs And Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Khandelwal | Whole-Time Director | 04 Jan 1994 | Current |
| Shiven Khandelwal | Whole-Time Director | 25 Jan 2020 | Current |
| Anuradha Khandelwal | Whole-Time Director | 15 Jul 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jul 2015 | Past |
| Pramod Abcsdd | Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 16 Jul 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 27 Jan 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elcon Drugs And Formulations Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 623.06% increase. The company also saw a substantial improvement in profitability, with a 672.72% increase in profit. The company's net worth Soared by an impressive increase of 375.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Elcon Drugs And Formulations had a promoter holding of 99.85% and a public holding of 0.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,469,150.00
₹58,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Feb 2025 | Hdfc Bank Limited | ₹1.47 M | Open |
| 25 Jan 2001 | State Bank Of India | ₹3.00 M | Open |
| 30 Sep 2017 | Others | ₹2.25 Cr | Satisfied |
| 29 Feb 2016 | Tata Capital Financial Services Limited | ₹2.00 Cr | Satisfied |
| 15 Oct 2004 | State Bank Of India | ₹2.70 M | Satisfied |
Explore comprehensive loan charge details -
Elcon Drugs And Formulations has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elcon Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elcon Drugs And Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 1.47 M with Charge ID 101077061 was registered on 05 Feb 2025. was recorded as a recent event.
Progress on Elcon Drugs And Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Elcon Drugs And Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
Progress on Shiven Khandelwal was appointed as a Whole-time director was appointed as a Whole-time director on 25 Jan 2020 & has been associated with this company since 5 years 10 months . was documented.
The activity A charge registered on 30 Sep 2017 via Charge ID 100145759 with Others was fully satisfied on 13 Jan 2020. was completed.
The activity A charge registered on 29 Feb 2016 via Charge ID 10625274 with Tata Capital Financial Services Limited was fully satisfied on 08 Dec 2017. was completed.
The CIN of Elcon Drugs And Formulations Limited is U24232RJ1994PLC007922.
Elcon Drugs And Formulations Limited is headquartered at G-2, G-3, G R Tower, Hathoj Mod, Bindayaka Road, Jaipur, Rajasthan, 302012.
Elcon Drugs And Formulations Limited was incorporated on 04 January 1994.
The current directors of Elcon Drugs And Formulations Limited are
The primary industry of Elcon Drugs And Formulations Limited is Trade.
Elcon Drugs And Formulations Limited is unlisted.
The authorized capital of Elcon Drugs And Formulations Limited is ₹8.00 M, and the paid-up capital is ₹7.72 M.
The compliance status of Elcon Drugs And Formulations Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX